Patents by Inventor Michael J. Young

Michael J. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969759
    Abstract: System and method are provided where parcels or packages are associated or grouped, into logical group or logical containerization of parcels or packages, without need for physical container, such that parcels or packages can be tracked as a group, for example with a unique group ID. Logical group may be tracked within specified logical zone on conveyor, transported, sorted and/or otherwise processed as unique logical group without need to be contained in physical container. System and method for automated sortation can accumulate set number or set volume of packages, and then process the accumulated set number or volume of packages.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: April 30, 2024
    Assignee: AEGIS SORTATION LLC
    Inventors: Anthony J. Young, Jeffrey Paul Henley, Kevin Raney, Robert Browder, Marvin Gregory Whitlock, Scott Crance, Ken Ice, Michael Karaglanis, Brian Yount, Barry Sweatt, Thomas M. Phillips, Logan Young
  • Patent number: 11957719
    Abstract: The present invention relates to substantially homogenous populations of human retinal progenitor cells having the following positive surface markers: SSEA4, CD73, PTK7 and PSA-NCAM. The invention also relates to method for preparing such substantially homogeneous cell populations from human tissue using cell sorting techniques.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: April 16, 2024
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Petr Y. Baranov
  • Patent number: 11949795
    Abstract: Systems, computer program products, and methods are described herein for tracking resources using non-fungible tokens. The present invention is configured to electronically receiving, over a distributed computing network from a computing device of a user, a request for a non-fungible token (NFT) for a resource; initiating a non-fungible token (NFT) generator on the resource in response to receiving the request; generating a unique digital signature for the resource; generating, using the NFT generator, the NFT, wherein the NFT comprises at least the unique digital signature for the resource; and record the NFT for the resource on a distributed ledger.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: April 2, 2024
    Assignee: BANK OF AMERICA CORPORATION
    Inventors: Michael Robert Young, James J. Siekman, Richard Seymour Scot
  • Patent number: 11919863
    Abstract: The disclosure is directed to improved methods for preparing substituted quinolinylcyclohexylpropanamide compounds.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: March 5, 2024
    Assignee: Bristol-Myers Squibb Company
    Inventors: Albert J. Delmonte, Benjamin M. Cohen, Kenneth Joseph Fraunhoffer, Sergei Kolotuchin, Francisco Gonzalez-Bobes, Gregory Louis Beutner, Adam Joseph Freitag, Michael Scott Bultman, Yu Fan, Prantik Maity, Ian Scott Young, Hilary Plake Beck, Maksim Osipov, Jay Patrick Powers, Maureen Kay Reilly, Hunter Paul Shunatona, James Ross Walker, Mikhail Zibinsky
  • Publication number: 20230313135
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: June 5, 2023
    Publication date: October 5, 2023
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Publication number: 20230090462
    Abstract: Progenitor cells were isolated, purified and expanded using a microfluidic based cell sorting approach. The methods were successfully in purifying cone progenitor cells (CPCs) defined based on a proliferative population expressing cone arrestin and Red/Green (R/G) opsin at greater than 80% using a two multistage approach.
    Type: Application
    Filed: March 16, 2020
    Publication date: March 23, 2023
    Inventors: Michael J. Young, Pierre Colombe, Deepti Singh
  • Publication number: 20220191693
    Abstract: A computer-implemented method for remote management of hardware security modules (HSMs) includes receiving a command request from a mobile device. The command request includes an encrypted key part and an encrypted signing key. The HSM decrypts the command request using a key associated with a security zone of the mobile device. The HSM decrypts the encrypted key part and the encrypted signing key. Decrypting the encrypted key part and the encrypted signing key includes using the key associated with the security zone of the mobile device and a key associated with a remote administrator associated with the mobile device. A command is generated for a domain with a target HSM. The command is generated using the decrypted key part and the decrypted signing key. The command is transmitted to the domain for execution by the target HSM. Various other methods, systems, and computer-readable media are also disclosed.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 16, 2022
    Inventors: Garry Joseph Sullivan, James Richard Coon, Michael Joseph Jordan, Michael J. Young, Jessica Doherty, Christopher V. DeRobertis
  • Publication number: 20220151258
    Abstract: Disclosed is a method for recovering protein hydrolysates from high-fat protein concentrates. The method can be used, for example, to produce a whey protein hydrolysate from the by-product retentate of the manufacture of whey protein isolates, as well as to isolate the milk fat globule membrane from a high-fat whey protein concentrate starting material.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 19, 2022
    Inventors: Michael J. Young, Loren S. Ward
  • Publication number: 20220117261
    Abstract: Disclosed is a method for making protein emulsions for use in making products such as meat substitutes, meat extenders, egg substitutes, dairy analogues, etc., as well as methods for using the emulsion(s) to make various meat substitutes, egg substitutes, dairy analogues, etc. Also disclosed are vegetable protein crumbles for use as meat substitutes, either alone or in combination with the emulsion(s).
    Type: Application
    Filed: December 31, 2021
    Publication date: April 21, 2022
    Inventors: Tucker J. Smith, Michael J. Young, Brent L. Petersen, Loren S. Ward
  • Publication number: 20210387912
    Abstract: A method for forming a treated reclaimed bottom ash sand and a treated reclaimed bottom ash sand. The method includes providing reclaimed bottom ash sand. The reclaimed bottom ash sand is contacted with an aqueous composition having 0.5 to 3.0 M NaOH for a time greater than about 4 hours. The NaOH contacted reclaimed bottom ash sand is rinsed and decanted and iron is removed to form a treated reclaimed bottom ash sand having reduced hydrogen formation in concrete compared to the hydrogen formation of concrete utilizing reclaimed bottom ash sand. The treated reclaimed bottom ash sand includes reactive aluminum of less than 50% by weight of the reactive aluminum in the reclaimed bottom ash sand and the treated reclaimed bottom ash sand includes less than 2 wt % iron. A concrete formed from the treated reclaimed bottom ash sand is also disclosed.
    Type: Application
    Filed: November 14, 2019
    Publication date: December 16, 2021
    Inventor: Michael J. YOUNG
  • Publication number: 20210236322
    Abstract: The present application is directed to a method and system for restraining a patient before, during, or after surgery that increases efficiency of the surgical setup process and minimizes risk of musculoskeletal damage to the patient, particularly in surgeries requiring a patient to be in a Trendelenburg position (e.g., robotic or laparoscopic surgeries). One or more restraints can be worn by a patient prior to surgery', and may function to redistribute the patients weight across the patients torso to reduce strain on the patients shoulders and back. The restraint(s) can be attached to a surgical table by way of an attachment mechanism coupled to the restraint(s) and the table. The attachment mechanism can secure the patient to the table by way of one or more straps, clips, and/or other intermediates. Optionally, the restraint(s) can fulfill other surgical needs, such as heat regulation and vascular compression.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 5, 2021
    Inventors: Michael J. Young, Craig Niederberger, Stephan Peter Pfanner, Andrew Graham, Julissa Garcia, Sweta Shah, Leigha Covnot, Zahra Ahsan, Kimberlee Wilkens, Cristian Luciano
  • Publication number: 20210198625
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 1, 2021
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Patent number: 10959059
    Abstract: Aspects of the invention include providing intelligent content recommendations to groups of people. A non-limiting example computer-implemented method includes identifying, by a processor, the presence of a plurality of users in a location. The method creates a virtual user with a virtual user profile, by the processor, from profiles of the plurality of users and provides, by the processor, a recommendation to the plurality of users of content to consume based on the virtual user's profile. The method serves, by the processor, the recommended content.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: March 23, 2021
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Christopher D. Wyble, Peter J. Mostachetti, Michael J. Young, Brian C. Main
  • Patent number: 10947501
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: March 16, 2021
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Publication number: 20200345785
    Abstract: The present invention relates to substantially homogenous populations of human retinal progenitor cells having the following positive surface markers: SSEA4, CD73, PTK7 and PSA-NCAM. The invention also relates to method for preparing such substantially homogeneous cell populations from human tissue using cell sorting techniques.
    Type: Application
    Filed: March 19, 2020
    Publication date: November 5, 2020
    Inventors: Michael J. Young, Petr Y. Baranov
  • Patent number: 10758572
    Abstract: The present invention relates to substantially homogenous populations of human retinal progenitor cells having the following positive surface markers: SSEA4, CD73, PTK7 and PSA-NCAM. The invention also relates to method for preparing such substantially homogeneous cell populations from human tissue using cell sorting techniques.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: September 1, 2020
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Petr Y. Baranov
  • Publication number: 20190019097
    Abstract: Systems and methods for automated node status determination are disclosed herein. The system can include a memory. The memory can include a Q-matrix that can include data identifying a relationship between at least a portion of a standard and at least one item of an assessment. The system can include at least one server. The at least one server can provide a first interim assessment including a first plurality of items. Each of the items can correspond to a child evidence node in a Bayesian network. The at least one server can generate first evidence by evaluating responses received to the first plurality of items from the first interim assessment and can calculate a mastery probability according to the Bayesian network of at least one parent node in the Bayesian network based on the generated first evidence.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 17, 2019
    Inventors: Amy Reilly, Paul Grudnitski, Michael J. Young
  • Publication number: 20180228811
    Abstract: Methods and compositions for glial cell-derived neurotrophic factor (GDNF) induction in the eye, and for treatment and/or prevention of retinal disorders are described.
    Type: Application
    Filed: December 11, 2015
    Publication date: August 16, 2018
    Inventors: Dwight M. Morrow, Kathryn L. McCabe, Hong Lin, Petr Y. Baranov, Michael J. Young
  • Publication number: 20170335280
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: June 2, 2017
    Publication date: November 23, 2017
    Applicant: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Patent number: 9677050
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: June 13, 2017
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov